ArticleBiomedicines2022

Human Blood Serum Inhibits Ductal Carcinoma Cells BT474 Growth and Modulates Effect of HER2 Inhibition.

Dmitrii Kamashev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.